Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial

Autor: Fabris, F., Pilger, E., Pabst, E., Kostner, G., Wautrecht, J. C., Baitsch, G., Breddin, K., Diehm, C., Podhaisky, H., Taute, B. M., Diamantoupolos, E. J., Aimar, T., Alari, G., Albano, S., Altamura, N., Arosio, E., Bortolon, M., Caccia, R., Carotta, M., Carzaniga, G., Catalano, M., Contini, P., Difolca, A., Dore, M., Falaschi, F., Franchini, B., Frare, C., Frascisco, M., Giansante, C., Giona, E., Giubbolini, M., Lucarelli, F., Marchitelli, E., Marcialis, M. R., Martignoni, A., Melillo, E., Minola, M., Monetti, D., Nenci, G., Paolicelli, M., Pasqualini, L., Perilli, E., Pettina, G., Poli, L., Radicchia, S., Rossi, M., Scandale, G., Scondotto, G., Sergi, D., Setacci, C., Spada, S., Todini, A. R., Vaudo, G., Verlato, F., Visona, A., Zannoni, M., Bielawiec, M., Jawien, A., Meissner, A., Michalak, J., Nizankowski, R., Wandzilak, M., Avram, J. A., Avram, R., Hancu, N., Marian, A., Marian, I., Murariu, M., Negrisanu, G., Olinic, D., Olinic, N., Trambitas, R., Veresiu, I., Victoria, I., Kozak, M., Mavri, A., Bahi, J. S., Bahi, P. S., Brunkwall, J., Gallino, A.

Publikováno v: Journal of Internal Medicine. 261:276-284

OBJECTIVE: To assess the prophylactic efficacy of aspirin and a high-dose antioxidant vitamin combination in patients with peripheral arterial disease (PAD) in terms of reduction of the risk of a first vascular event (myocardial infarction, stroke, v

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63cbb718befe533ebe1f24af0df59878
https://doi.org/10.1111/j.1365-2796.2006.01763.x

Comparative study on the in vitro and in vivo activities of heparinoids derivative investigated on the animal model

Autor: Kłoczko J, J Giedrojć, Bielawiec M, Klimiuk M, Breddin Hk, P Radziwon

Publikováno v: Journal of cardiovascular pharmacology. 34(3)

In this study we compared the antithrombotic and anticoagulant properties of sodium and calcium derivatives of pentosan polysulfate (Na-PPS, Ca-PPS), unfractionated heparin (UFH), and low-molecular-weight heparin (Fraxiparin). The antithrombotic effe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35b6c83e8665d0195c30ef645fd9e6a9
https://pubmed.ncbi.nlm.nih.gov/10470990

Subcutaneous low molecular weight heparin versus subcutaneous unfractionated heparin in the treatment of deep vein thrombosis: a Polish multicenter trial

Autor: Meissner Aj, Ciesielski L, Czestochowska E, Filipecki S, Lopaciuk S, Sowier J, Glowinski S, Zawilska K, Bielawiec M

Publikováno v: Thrombosis and haemostasis. 68(1)

SummaryIn a prospective multicenter trial, 149 consecutive patients with phlebographically proven proximal and/or distal deep vein thrombosis of the leg were randomly allocated to receive subcutaneously for 10 days either low molecular weight heparin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a68020476b8625dfac20e5b4b811dce
https://pubmed.ncbi.nlm.nih.gov/1325076

Human monocytes release plasma serine protease inhibitors in vitro

Autor: Kłoczko J, Marzenna Galar, Bielawiec M, P. Radziwon, J. Giedrojc

Publikováno v: Haemostasis. 20(4)

The ability of human peripheral blood monocytes to secrete plasma serine protease inhibitors was studied. Monocytes from blood obtained from healthy young adult volunteers were cultured for up to 36 h with and without lipopolysaccharide from Escheric

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c94f7214159e08cac975e0faaf1ba508
https://pubmed.ncbi.nlm.nih.gov/1700759

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.